Loading...
OTCM
NDTP
Market cap9mUSD
Jul 28, Last price  
0.06USD
Jan 2017
60,900.00%
IPO
-88.91%
Name

NDT Pharmaceuticals Inc

Chart & Performance

D1W1MN
P/E
P/S
EPS
Div Yield, %
Shrs. gr., 5y
250.51%
Rev. gr., 5y
-42.26%
Revenues
0k
0007,515000000000
Net income
-79k
-5,773-51,761-1,036,698-246,240-260,674-87,330-1,929-1,2400000-79,033
CFO
-18k
-323-30,553-39,440-14,694-261,8740000-17,763

Profile

NDT Pharmaceuticals Inc., a biotechnology company, focuses on developing various therapies for severe neurological disorders associated with traumatic brain Injury. The company is based in Vienna, Virginia.
IPO date
Dec 14, 2006
Employees
Domiciled in
CA
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
(168)
Tax Rate
NOPAT
168
Net income
(79)
 
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
(143)
Cash flow
Cash from operating activities
(18)
CAPEX
3
Cash from investing activities
Cash from financing activities
18
FCF
209
Balance
Cash
647
Long term investments
142
Excess cash
143
Stockholders' equity
(91)
Invested Capital
192
ROIC
87.46%
ROCE
EV
Common stock shares outstanding
160,004
Price
0.06
 
Market cap
9,800
 
EV
9,657
EBITDA
EV/EBITDA
Interest
Interest/NOPBT